前收市價 | 66.00 |
開市 | 65.68 |
買盤 | 66.30 x 100 |
賣出價 | 66.56 x 200 |
今日波幅 | 65.68 - 67.30 |
52 週波幅 | 37.64 - 70.81 |
成交量 | |
平均成交量 | 145,693 |
市值 | 1.396B |
Beta 值 (5 年,每月) | 0.80 |
市盈率 (最近 12 個月) | 78.26 |
每股盈利 (最近 12 個月) | 0.85 |
業績公佈日 | 2024年5月10日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 79.80 |
GSK's revenues benefit from strong growth across the Specialty Medicines and Vaccines segments. The company raises guidance for earnings and sales for the full year.
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Sage Therapeutics' (SAGE) first-quarter 2024 results are mixed as earnings miss estimates, but sales beat the mark. The newly-launched depression drug Zurzuvae drives the company's top line.